Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Pain medicine (Malden, Mass.)

• Publication date

  2006-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1526-4637.2006.00207.XPMID 17014595
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rosiglitazone

  2012cited by this paper
• Duloxetine in the treatment of major depressive disorder

  2007cited by this paper
• Duloxetine pharmacology: profile of a dual monoamine modulator.

  2006cited by this paper
• A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.

  2005cited by this paper
• Immediate switching of antidepressant therapy: results from a clinical trial of duloxetine.

  2005cited by this paper
• Chronic Neuropathic Pain: Mechanisms, Diagnosis, and Treatment

  2005cited by this paper
• Duloxetine vs. placebo in patients with painful diabetic neuropathy

  2005cited by this paper
• Weight gain during insulin therapy in patients with type 2 diabetes mellitus.

  2004cited by this paper
• Pregabalin relieves symptoms of painful diabetic neuropathy

  2004cited by this paper
• Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

  2004cited by this paper
• Neuropathic pain symptoms relative to overall pain rating.

  2004cited by this paper
• Duloxetine in the Treatment of Depression: A Double-Blind Placebo-Controlled Comparison With Paroxetine

  2004cited by this paper
• Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials.

  2003cited by this paper
• Diabetic polyneuropathy. Risk factors, patterns of presentation, diagnosis, and treatment.

  2003cited by this paper
• Duloxetine in the long-term treatment of major depressive disorder.

  2003cited by this paper
• Safety of Antidepressant Drugs in the Patient with Cardiac Disease: A Review of the Literature

  2003cited by this paper
• Use of gabapentin to reduce chronic neuropathic pain in Fabry disease

  2003cited by this paper
• Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression.

  2002cited by this paper
• Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.

  2002cited by this paper
• Duloxetine for the treatment of major depressive disorder.

  2002cited by this paper
• Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine

  2002cited by this paper
• Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.

  2002cited by this paper
• Thiazolidinediones and type 2 diabetes: new drugs for an old disease

  2002cited by this paper
• Antidepressants as analgesics: a review of randomized controlled trials.

  2001cited by this paper
• The efficacy of newer antidepressants in the treatment of chronic pain: a review of current literature.

  2000cited by this paper
• The management challenges of chronic pain: the role of antidepressants.

  2000cited by this paper
• Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study.

  2000cited by this paper
• Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents.

  2000cited by this paper
• Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy.

  2000cited by this paper
• Tricyclic Antidepressant Use in Diabetic Neuropathy

  1999cited by this paper
• Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain.

  1999cited by this paper
• Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus: a Randomized Controlled Trial

  1999cited by this paper
• Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

  1999cited by this paper
• Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

  1998cited by this paper
• Neuroanatomy of the pain system and of the pathways that modulate pain.

  1997cited by this paper
• Hypoglycemia in the Diabetes Control and Complications Trial

  1997cited by this paper
• The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

  1997cited by this paper
• Diabetes in America, 2nd edition

  1995cited by this paper
• Cardiovascular safety in depressed patients: focus on venlafaxine.

  1995cited by this paper
• Cardiovascular safety in depressed patients: focus on venlafaxine.

  1995cited by this paper
• A Practical Two-Step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy

  1994cited by this paper
• Pain assessment: global use of the Brief Pain Inventory.

  1994cited by this paper
• The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort

  1993cited by this paper
• LY248686, A New Inhibitor of Serotonin and Norepinephrine Uptake

  1993cited by this paper
• The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered.

  1993cited by this paper
• The projections of noradrenergic neurons in the A5 catecholamine cell group to the spinal cord in the rat: anatomical evidence that A5 neurons modulate nociception.

  1993cited by this paper
• Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.

  1992cited by this paper
• The Use of Antidepressants in the Treatment of Chronic Pain

  1991cited by this paper
• Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study.

  1990cited by this paper
• Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood

  1987cited by this paper
• Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry.

  1984cited by this paper
• Psychotropic drugs.

  1984cited by this paper
• Changes in the effects of stimulation of locus coeruleus and nucleus raphe magnus following dorsal rhizotomy.

  1983cited by this paper

• A Systematic Guideline by the ASPN Workgroup on the Evidence, Education, and Treatment Algorithm for Painful Diabetic Neuropathy: SWEET

  2024cites this paper
• Effectiveness of Duloxetine versus Other Therapeutic Modalities in Patients with Diabetic Neuropathic Pain: A Systematic Review and Meta-Analysis

  2024cites this paper
• Spinal cord vascular degeneration impairs duloxetine penetration

  2023cites this paper
• Understanding the role of hyperglycemia and the molecular mechanism associated with diabetic neuropathy and possible therapeutic strategies.

  2023cites this paper
• Efficacy and Safety of TENS and Duloxetine in Patients with Painful Diabetic Neuropathy: A Single Blind Randomized Clinical Trial

  2021cites this paper
• Painful diabetic polyneuropathy: evidence-based diagnosis and treatment

  2021cites this paper
• Management of Neuropathic Pain in the Geriatric Population.

  2021cites this paper
• Features of postoperative therapy in patients with type ІІ diabetes

  2020cites this paper
• A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine

  2020cites this paper
• Nonopioid Pharmacologic Treatments for Chronic Pain

  2020cites this paper
• Duloxetine protects against experimental diabetic retinopathy in mice through retinal GFAP downregulation and modulation of neurotrophic factors.

  2019cites this paper
• Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial

  2019cites this paper
• Diabetic neuropathy: A focus on the testing method

  2018cites this paper
• Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review

  2018cites this paper
• Evaluating the risk of QTc prolongation associated with antidepressant use in older adults: a review of the evidence

  2018cites this paper
• Alternatives to Opioids in the Pharmacologic Management of Chronic Pain Syndromes: A Narrative Review of Randomized, Controlled, and Blinded Clinical Trials

  2017cites this paper
• Comparative RNA‐Seq transcriptome analyses reveal distinct metabolic pathways in diabetic nerve and kidney disease

  2017cites this paper
• 40 – Diagnosis and Treatment of Complex Regional Pain Syndrome

  2017cites this paper
• Adult Complex Regional Pain Syndrome Type I: A Narrative Review

  2017cites this paper
• Diabetic Neuropathy: A Position Statement by the American Diabetes Association

  2016cites this paper
• Efficacy and safety of 40 mg or 60 mg duloxetine in Japanese adults with diabetic neuropathic pain: Results from a randomized, 52‐week, open‐label study

  2015cites this paper
• Unintended positive and negative effects of drugs on lipoproteins

  2015cites this paper
• From guideline to patient: a review of recent recommendations for pharmacotherapy of painful diabetic neuropathy.

  2015cites this paper
• Pharmacogenetics and analgesic effects of antidepressants in chronic pain management.

  2015cites this paper
• Complex regional pain syndrome type I: a comprehensive review

  2015cites this paper
• A review of the clinical utility of duloxetine in the treatment of diabetic peripheral neuropathic pain

  2015influential citation
• Comparative Evaluation of Pregabaline, Gabapentine, Sertraline and Duloxetine in Painful Diabetic Non Insulin-dependent Neuropathy☆

  2015cites this paper
• Systematic Review and Meta‐Analysis of Pharmacological Therapies for Painful Diabetic Peripheral Neuropathy

  2014cites this paper
• Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain

  2014cites this paper
• Combining Opioid and Adrenergic Mechanisms for Chronic Pain

  2014cites this paper
• Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia.

  2014cites this paper
• A Randomized, Double‐Blind, Placebo‐Controlled Trial of Duloxetine for the Treatment of Pain in Patients with Multiple Sclerosis

  2014cites this paper
• The Management of Diabetic Neuropathy in CKD and Dialysis Patients

  2014cites this paper
• Current options and perspectives in the treatment of diabetic neuropathy.

  2013cites this paper
• Douleur chronique : rôle de la pharmacogénétique dans la résistance aux antidépresseurs

  2013cites this paper
• Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.

  2013cites this paper
• Pharmacological treatment patterns in neuropathic pain--lessons from Swedish administrative registries.

  2013cites this paper
• Impact of treatments for painful diabetic polyneuropathies on patients

  2013cites this paper
• A Cost-Utility Analysis of Pregabalin Versus Duloxetine for the Treatment of Painful Diabetic Neuropathy

  2012cites this paper
• Dosing Pattern Comparison Between Duloxetine and Pregabalin among Patients with Diabetic Peripheral Neuropathic Pain

  2012cites this paper
• Predictors of Duloxetine versus Other Treatments among Veterans with Diabetic Peripheral Neuropathic Pain: A Retrospective Study

  2012cites this paper
• Recent Advances in the Pharmacological Management of Pain

  2012cites this paper
• Efficacy and safety of the α4β2 neuronal nicotinic receptor agonist ABT-894 in patients with diabetic peripheral neuropathic pain

  2012cites this paper
• Duloxetine in the management of diabetic peripheral neuropathic pain

  2011influential citation
• Duloxetine-Induced Liver Injury in Patients with Major Depressive Disorder

  2011cites this paper
• Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin

  2011cites this paper
• A Comparative Trial to Evaluate Amitriptyline and Duloxetine in Painful Diabetic Neuropathy: A randomized, double-blind, cross-over clinical trial

  2011cites this paper
• Update on the management of diabetic polyneuropathies

  2011cites this paper
• Preliminary assessment of a neuropathic pain treatment and referral algorithm for patients with cancer.

  2011cites this paper
• Weight change with long‐term duloxetine use in chronic painful conditions: an analysis of 16 clinical studies

  2011cites this paper
• A Comparative Evaluation of Amitriptyline and Duloxetine in Painful Diabetic Neuropathy

  2011cites this paper
• Review: Electrical spinal cord stimulation in painful diabetic polyneuropathy, a systematic review on treatment efficacy and safety

  2011influential citation
• Long-term safety of duloxetine during open-label compassionate use treatment of patients who completed previous duloxetine clinical trials

  2010cites this paper
• The management of diabetic neuropathy in CKD.

  2010cites this paper
• Duloxetine versus placebo in the treatment of patients with diabetic neuropathic pain in China.

  2010cites this paper
• The Association between Conventional Antidepressants and the Metabolic Syndrome

  2010cites this paper
• Analgésicos coadyuvantes para el tratamiento del dolor crónico

  2010influential citation
• diabetic neuropathy Review : Novel insights on diagnosis , cause and treatment of diabetic neuropathy : focus on painful

  2010influential citation
• Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study.

  2010cites this paper
• Cholestatic Jaundice Induced by Duloxetine in a Patient with Major Depressive Disorder

  2010cites this paper
• Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine

  2010influential citation
• Duloxetine: Its Role in the Management of Chronic Pain

  2010cites this paper
• Review: Novel insights on diagnosis, cause and treatment of diabetic neuropathy: focus on painful diabetic neuropathy

  2010influential citation
• Duloxetina: dos años y medio de experiencia

  2009cites this paper
• Duloxetine for treating painful neuropathy or chronic pain.

  2009cites this paper
• Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain

  2009cites this paper
• Non-fatal overdose of duloxetine in combination with other antidepressants and benzodiazepines

  2009cites this paper
• Systemic amitriptyline administration does not prevent the increased thermal response induced by paradoxical sleep deprivation.

  2009cites this paper
• The Brief Pain Inventory User Guide

  2009cites this paper
• Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress

  2009influential citation
• Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options.

  2008cites this paper
• The hepatic safety profile of duloxetine: a review

  2008cites this paper
• Duloxetine-Associated Tachycardia

  2008cites this paper
• Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials

  2008cites this paper
• Antidepressant use in painful rheumatic conditions.

  2008cites this paper
• Placebo response in neuropathic pain trials☆

  2008cites this paper
• An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.

  2007cites this paper
• Treatment options for the management of diabetic painful neuropathy: best current evidence

  2007cites this paper
• HPLC analysis of the novel antidepressant duloxetine in human plasma after an original solid-phase extraction procedure.

  2007cites this paper
• Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: scientific basis for overlapping clinical efficacy from a single drug, duloxetine

  2007cites this paper
• Diabetic Retinopathy and Diabetic Neuropathy

  2007cites this paper
• Efectos de duloxetina y amitriptilina en el dolor neuropático: estudio en 180 casos

  2007cites this paper
• Clinical manifestations and current treatment options for diabetic neuropathies.

  2007cites this paper
• Duloxetine status.

  2007cites this paper
• 40 Anesthetic Techniques in Pain Management Anti-inflammatory Drugs

  2007cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  2007cites this paper
• Antidepressant-lnduced Liver Injury

  2007cites this paper
• Pharmacologic therapies for complex regional pain syndrome

  2007cites this paper
• Duloxetine in the treatment of diabetic peripheral neuropathic pain

  2006cites this paper
• Duloxetine versus Routine Care in the Long-Term Management of Diabetic Peripheral Neuropathic Pain

  2006cites this paper
• Duloxetine in the treatment of major depressive disorder: an assessment of the relationship between outcomes and episode characteristics

  2006cites this paper
• EFFECTS OF ACETYLCHOLINE ON ISOLATED URINARY BLADDERS OF NORMAL AND STREPTOZOTOCIN-TREATED DIABETIC RATS

  2006cites this paper